AKT1 and osteosarcoma: In summary, this study provides comprehensive evidence that cordycepin inhibits the growth and apoptosis of osteosarcoma cells by activating AMPK and inhibiting the AKT/mTOR signaling pathway and enhances the sensitivity of osteosarcoma cells to cisplatin, suggesting that cordycepin is a promising novel treatment for osteosarcoma.